Phase 4
N=102
Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction
Anesthesia Intubation Complication
Bottom Line
View on ClinicalTrials.gov: NCT01150838 ↗Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Estimated Propofol Doses Producing 50% Excellent Intubation Conditions — 1.48; 0.00; 0.07; 2.35 mg/kg
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- propofol (Drug)
- Age
- Pediatric · 1+ yrs
- Sex
- All
- Sponsor
- University of Virginia
- Primary completion
- Jun 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Estimated Propofol Doses Producing 50% Excellent Intubation Conditions |
1.48; 0.00; 0.07; 2.35; 2.33 | — |
Summary
The purpose of this study is to determine the amount of propofol required to achieve 50% of patients obtaining a perfect ("excellent") intubation score of 5 on the Steyn modification of the Helbo-Hansen Intubation Score, when placing a tracheal tube in children 1-6 years and 6-12 years (division of age groups at 6th birthday) of age, under a specific induction and ventilation sequence as specified in this study design.
Eligibility Criteria
Inclusion Criteria
- Informed consent / assent
- Ages 1-11 years (12 - 132 months)
- American Society of Anesthesiology (ASA) physical status 1 or 2, which implies that the patient has no comorbidity that limits daily function.
- Scheduled for non-emergent surgery/ procedure under general anesthesia in which the anesthesia team intends to place an endotracheal tube
- Expected routine intubation according to physical exam and history
- Weight under 50 kg
Exclusion Criteria
- Requires neuromuscular blocking agents
- Emergent surgery / procedure
- Expected difficult intubation
- ASA physical status 3 or 4
- Weight over 50 kg
- Age under 12 months or over 132 months
- Allergy to study drugs to be used
Data sourced from ClinicalTrials.gov (NCT01150838). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.